Immunovant, Inc. IMVT Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s software and technology licenses, net?
- Immunovant, Inc. (IMVT) reported software and technology licenses, net of $7.68M in Q1 2026.
- How has Immunovant, Inc.'s software and technology licenses, net changed year-over-year?
- Immunovant, Inc.'s software and technology licenses, net increased by 0.8% year-over-year, from $7.62M to $7.68M.